Aqr Capital Management LLC Cytokinetics Inc Transaction History

Aqr Capital Management LLC

$75.6 Billion
Q4 2024

A detailed history of Aqr Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 33,253 shares of CYTK stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,253

Previous 37,357 10.99%

Holding current value

$1.51 Million

Previous $1.97 Million 20.69%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $190,261 - $240,576	-4,104 Reduced 10.99%	33,253 $1.56 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $202,626 - $237,992	3,956 Added 11.84%	37,357 $1.97 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $151,620 - $237,758	3,168 Added 10.48%	33,401 $1.81 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $160,841 - $272,635	2,523 Added 9.11%	30,233 $2.12 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $44,862 - $139,344	-1,669 Reduced 5.68%	27,710 $2.31 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $144,118 - $179,096	-4,892 Reduced 14.27%	29,379 $865,000
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $177,159 - $221,313	-5,431 Reduced 13.68%	34,271 $1.12 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $64,117 - $87,854	-1,922 Reduced 4.62%	39,702 $1.4 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $29,045 - $41,501	812 Added 1.99%	41,624 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $101,629 - $143,769	2,637 Added 6.91%	40,812 $1.98 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $42,989 - $61,981	1,267 Added 3.43%	38,175 $1.5 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $16,148 - $24,978	543 Added 1.49%	36,908 $1.36 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $901,000 - $1.22 Million	26,230 Added 258.81%	36,365 $1.66 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $111,655 - $152,277	-5,642 Reduced 35.76%	10,135 $201,000
Q1 2021 May 17, 2021	SELL	$18.57 - $25.68 $11,216 - $15,510	-604 Reduced 3.69%	15,777 $367,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $51,822 - $97,159	-3,396 Reduced 17.17%	16,381 $340,000
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $22,905 - $32,232	-1,113 Reduced 5.33%	19,777 $428,000
Q2 2020 Aug 17, 2020	SELL	$11.15 - $24.64 $8,574 - $18,948	-769 Reduced 3.55%	20,890 $492,000
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $12,626 - $23,520	1,443 Added 7.14%	21,659 $255,000
Q4 2019 Feb 14, 2020	BUY	$7.95 - $11.84 $34,813 - $51,847	4,379 Added 27.65%	20,216 $214,000
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $7,043 - $9,276	651 Added 4.29%	15,837 $180,000
Q1 2018 May 15, 2018	SELL	$7.2 - $10.05 $84,405 - $117,816	-11,723 Reduced 43.57%	15,186 $109,000
Q4 2017 Feb 14, 2018	BUY	$7.25 - $15.65 $9,497 - $20,501	1,310 Added 5.12%	26,909 $219,000
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $307,188 - $383,985	25,599	25,599 $371,000

Others Institutions Holding CYTK

# of Institutions

395

Shares Held

122M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.27B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Cytokinetics Inc Transaction History